Read more about LumaWave's recent updates!
We're excited to welcome Keerthi and Suraj to our growing team. As we advance our photoacoustic platform, their expertise will strengthen our capabilities across system development, engineering, and product translation.
LumaWave Founder and CEO Dr. Vinoin Vincely has been selected as a member of Gambit's 2026 40 Under 40 class, recognizing emerging leaders making a significant impact across New Orleans.
Read This ArticleLumaWave, in partnership with Tulane university, has received a $1.5 million ARPA-H award to advance a groundbreaking fetal monitoring technology that can directly measure oxygen levels in fetal tissue during pregnancy and labor, providing clinicians with real-time insights into fetal health, improving decision-making during labor and helping reduce adverse birth outcomes.
Read This ArticleCEO Dr. Vinoin Devpaul Vincely places first at Tulane's Open Season presenting LumaWave's photoacoustic technology for continous fetal oximetery.
Read This ArticleCEO Dr. Vinoin Vincely places second at the 2026 Wound Healing Society's WoundShark Innovation pitch competition presenting LumaWave's platform photoacoustic technology.
CTO Dr. Carolyn Bayer places second at Tulane's Demo Day presenting LumaWave's platform photoacoustic technology.
Read This ArticleWe are happy to announce our most recent publication in Biomedical Optics Express. This validation of our technical approach is an exciting new development for LumaWave.
Read This ArticleLumaWave was featured in an article by Tulane's Innovation Institute, highlighting the team's progress in developing portable photoacoustic imaging technology. The feature showcases how the team is leveraging the NSF I-Corps program to evaluate clinical needs and market potential, underscoring LumaWave's commitment to advancing accessible diagnostic tools for vascular health.
Read This ArticleCEO Dr. Vinoin Devpaul Vincely wins Tulane's 5th Open Medical Innovation Challenge presenting LumaWave's point-of-care photoacoustic imaging device aimed at the early detection of peripheral artery disease (PAD).
Read This ArticleLumaWave's team was awarded the Tulane PPOC fund to develop a proof of concept prototype of a low-cost, point-of-care photoacoustic imaging prototype for assessment of tissue ischemia. The award marks a key milestone in translating fundamental research from the Bayer Lab into a viable clinical solution.
Read This Article